Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 225

1.

Alzheimer disease pathology and longitudinal cognitive performance in the oldest-old with no dementia.

Balasubramanian AB, Kawas CH, Peltz CB, Brookmeyer R, Corrada MM.

Neurology. 2012 Aug 28;79(9):915-21. doi: 10.1212/WNL.0b013e318266fc77. Epub 2012 Aug 15.

2.

Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old.

Robinson JL, Molina-Porcel L, Corrada MM, Raible K, Lee EB, Lee VM, Kawas CH, Trojanowski JQ.

Brain. 2014 Sep;137(Pt 9):2578-87. doi: 10.1093/brain/awu190. Epub 2014 Jul 9.

3.

"End-stage" neurofibrillary tangle pathology in preclinical Alzheimer's disease: fact or fiction?

Abner EL, Kryscio RJ, Schmitt FA, Santacruz KS, Jicha GA, Lin Y, Neltner JM, Smith CD, Van Eldik LJ, Nelson PT.

J Alzheimers Dis. 2011;25(3):445-53. doi: 10.3233/JAD-2011-101980.

4.

APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old.

Berlau DJ, Corrada MM, Head E, Kawas CH.

Neurology. 2009 Mar 3;72(9):829-34. doi: 10.1212/01.wnl.0000343853.00346.a4.

5.

Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.

Price JL, McKeel DW Jr, Buckles VD, Roe CM, Xiong C, Grundman M, Hansen LA, Petersen RC, Parisi JE, Dickson DW, Smith CD, Davis DG, Schmitt FA, Markesbery WR, Kaye J, Kurlan R, Hulette C, Kurland BF, Higdon R, Kukull W, Morris JC.

Neurobiol Aging. 2009 Jul;30(7):1026-36. doi: 10.1016/j.neurobiolaging.2009.04.002. Epub 2009 Apr 18.

6.

Education, cognitive function, and severity of neuropathology in Alzheimer disease.

Koepsell TD, Kurland BF, Harel O, Johnson EA, Zhou XH, Kukull WA.

Neurology. 2008 May 6;70(19 Pt 2):1732-9. Epub 2007 Dec 26.

PMID:
18160675
7.

Factors associated with resistance to dementia despite high Alzheimer disease pathology.

Erten-Lyons D, Woltjer RL, Dodge H, Nixon R, Vorobik R, Calvert JF, Leahy M, Montine T, Kaye J.

Neurology. 2009 Jan 27;72(4):354-60. doi: 10.1212/01.wnl.0000341273.18141.64.

8.

Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and AD.

Sabbagh MN, Cooper K, DeLange J, Stoehr JD, Thind K, Lahti T, Reisberg B, Sue L, Vedders L, Fleming SR, Beach TG.

Curr Alzheimer Res. 2010 Jun;7(4):280-6.

9.

Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.

Monsell SE, Kukull WA, Roher AE, Maarouf CL, Serrano G, Beach TG, Caselli RJ, Montine TJ, Reiman EM.

JAMA Neurol. 2015 Oct;72(10):1124-31. doi: 10.1001/jamaneurol.2015.1721.

PMID:
26302353
10.

Relation of neuropathology to cognition in persons without cognitive impairment.

Bennett DA, Wilson RS, Boyle PA, Buchman AS, Schneider JA.

Ann Neurol. 2012 Oct;72(4):599-609. doi: 10.1002/ana.23654.

11.

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

Berg L, McKeel DW Jr, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders AM.

Arch Neurol. 1998 Mar;55(3):326-35.

PMID:
9520006
12.

Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia.

Bancher C, Jellinger K, Lassmann H, Fischer P, Leblhuber F.

Eur Arch Psychiatry Clin Neurosci. 1996;246(3):137-46.

PMID:
8739399
13.

Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognition.

Riley KP, Jicha GA, Davis D, Abner EL, Cooper GE, Stiles N, Smith CD, Kryscio RJ, Nelson PT, Van Eldik LJ, Schmitt FA.

J Alzheimers Dis. 2011;25(4):707-17. doi: 10.3233/JAD-2011-102133.

14.

Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology.

Arvanitakis Z, Grodstein F, Bienias JL, Schneider JA, Wilson RS, Kelly JF, Evans DA, Bennett DA.

Neurology. 2008 Jun 3;70(23):2219-25. doi: 10.1212/01.wnl.0000313813.48505.86.

PMID:
18519870
15.

Age, Alzheimer's disease and dementia in the Baltimore Longitudinal Study of Ageing.

Dolan D, Troncoso J, Resnick SM, Crain BJ, Zonderman AB, O'Brien RJ.

Brain. 2010 Aug;133(Pt 8):2225-31. doi: 10.1093/brain/awq141. Epub 2010 Jul 20.

16.

Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.

Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS.

Neurology. 2005 Mar 8;64(5):834-41.

PMID:
15753419
17.

Role of the neuropathology of Alzheimer disease in dementia in the oldest-old.

Haroutunian V, Schnaider-Beeri M, Schmeidler J, Wysocki M, Purohit DP, Perl DP, Libow LS, Lesser GT, Maroukian M, Grossman HT.

Arch Neurol. 2008 Sep;65(9):1211-7. doi: 10.1001/archneur.65.9.1211.

18.

Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both.

Kraybill ML, Larson EB, Tsuang DW, Teri L, McCormick WC, Bowen JD, Kukull WA, Leverenz JB, Cherrier MM.

Neurology. 2005 Jun 28;64(12):2069-73.

19.

Alzheimer disease pathology in subjects without dementia in 2 studies of aging: the Nun Study and the Adult Changes in Thought Study.

SantaCruz KS, Sonnen JA, Pezhouh MK, Desrosiers MF, Nelson PT, Tyas SL.

J Neuropathol Exp Neurol. 2011 Oct;70(10):832-40. doi: 10.1097/NEN.0b013e31822e8ae9.

20.

Striatal amyloid plaque density predicts Braak neurofibrillary stage and clinicopathological Alzheimer's disease: implications for amyloid imaging.

Beach TG, Sue LI, Walker DG, Sabbagh MN, Serrano G, Dugger BN, Mariner M, Yantos K, Henry-Watson J, Chiarolanza G, Hidalgo JA, Souders L.

J Alzheimers Dis. 2012;28(4):869-76. doi: 10.3233/JAD-2011-111340.

Items per page

Supplemental Content

Write to the Help Desk